Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CKD-331 by Chong Kun Dang Pharmaceutical for Hyperlipidemia: Likelihood of Approval
CKD-331 is under clinical development by Chong Kun Dang Pharmaceutical and currently in Phase III for Hyperlipidemia. According to GlobalData,...
Data Insights
CKD-331 by Chong Kun Dang Pharmaceutical for Hypertension: Likelihood of Approval
CKD-331 is under clinical development by Chong Kun Dang Pharmaceutical and currently in Phase I for Hypertension. According to GlobalData,...